Quanterix Ownership | Who Owns Quanterix?
Quanterix Ownership Summary
Quanterix is owned by 89.38% institutional investors, 6.55% insiders, and 4.07% retail investors. Portolan capital management is the largest institutional shareholder, holding 9.34% of QTRX shares. CT (Lux) American Smaller Com 9U USD is the top mutual fund, with 4.08% of its assets in Quanterix shares.
QTRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Quanterix | 89.38% | 6.55% | 4.07% |
Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
Industry | Medical Device Stocks | 52.08% | 10.61% | 37.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Portolan capital management | 3.63M | 9.34% | $24.16M |
Ameriprise financial | 3.21M | 8.34% | $34.08M |
Blackrock | 3.14M | 8.23% | $41.45M |
Blackrock funding, inc. /de | 2.92M | 7.52% | $19.45M |
Alliancebernstein | 2.44M | 6.35% | $25.94M |
Vanguard group | 2.22M | 5.77% | $23.57M |
Invenomic capital management lp | 1.14M | 2.94% | $7.61M |
William blair investment management | 1.13M | 2.90% | $7.50M |
Easterly investment partners | 1.08M | 2.79% | $7.21M |
Blue water life science advisors, lp | 957.75K | 2.46% | $6.37M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Blue water life science advisors, lp | 957.75K | 5.04% | $6.37M |
Portolan capital management | 3.63M | 1.51% | $24.16M |
Trium capital llp | 688.60K | 1.46% | $3.74M |
Ashford capital management | 771.30K | 1.38% | $10.19M |
Tikvah management | 571.62K | 1.22% | $3.80M |
Easterly investment partners | 1.08M | 0.52% | $7.21M |
Kent lake capital | 75.00K | 0.45% | $990.75K |
Invenomic capital management lp | 1.14M | 0.43% | $7.61M |
Parkman healthcare partners | 515.99K | 0.39% | $3.43M |
Empire financial management company | 123.98K | 0.24% | $824.47K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ameriprise financial | 3.21M | 0.01% | 1.69M |
Ubs group | 934.55K | 0.00% | 913.39K |
Balyasny asset management | 767.80K | 0.01% | 723.29K |
Portolan capital management | 3.63M | 1.51% | 670.23K |
Blue water life science advisors, lp | 957.75K | 5.04% | 585.57K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 55.71K | 0.00% | -2.13M |
Lord, abbett | - | - | -1.76M |
Pier capital | - | - | -848.35K |
Alliancebernstein | 2.44M | 0.01% | -825.80K |
Eventide asset management | - | - | -615.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Parkman healthcare partners | 515.99K | 0.39% | 515.99K | $3.43M |
Marshall wace, llp | 444.19K | 0.00% | 444.19K | $2.95M |
Cubist systematic strategies | 287.23K | 0.01% | 287.23K | $1.87M |
Susquehanna portfolio strategies | 158.53K | 0.02% | 158.53K | $1.05M |
Two sigma investments, lp | 56.96K | 0.00% | 56.96K | $605.51K |
Sold Out
Holder | Change |
---|---|
Manchester capital management | -23.00 |
Innealta capital | -26.00 |
Allworth financial lp | -27.00 |
Ronald blue trust | -31.00 |
National bank of canada /fi/ | -33.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 135 | -10.60% | 34,762,673 | -0.84% | 89 | 1.09% | 70 | -23.91% | 41 | 17.14% |
Mar 31, 2025 | 5 | -96.82% | 897,525 | -97.43% | 2 | 0.03% | 5 | -93.98% | - | -100.00% |
Dec 31, 2024 | 156 | 3.31% | 34,445,404 | 3.64% | 89 | 1.20% | 83 | 20.29% | 43 | -17.31% |
Sep 30, 2024 | 149 | -4.49% | 33,225,425 | 2.54% | 86 | 1.20% | 67 | -14.10% | 52 | 8.33% |
Jun 30, 2024 | 155 | -6.63% | 32,401,996 | 0.36% | 84 | 1.17% | 78 | -1.27% | 47 | -16.07% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
CT (Lux) American Smaller Com 9U USD | 1.89M | 4.08% | -11.46K |
Strategic Advisers U.S. Total Stock | 1.89M | 4.07% | 67.99K |
Strategic Advisers U.S. Total Stock{mg} | 1.45M | 3.79% | 91.44K |
Strategic Advisers Small-Mid Cap | 1.30M | 3.39% | 283.56K |
Vanguard US Total Market Shares ETF | 1.15M | 2.96% | - |
Vanguard Total Stock Mkt Idx Inv | 1.25M | 2.69% | 102.12K |
CT American Smaller Coms(US) InstAccGBP | 1.23M | 2.65% | 8.22K |
AB Small Cap Growth A | 1.26M | 2.53% | -30.56K |
iShares Russell 2000 ETF | 1.01M | 2.18% | - |
Eventide Healthcare & Life Sciences I | 615.00K | 1.59% | 615.00K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 12, 2025 | Sriram Vandana | Chief Financial Officer | Buy | $19.88K |
Jun 13, 2025 | WALT DAVID R | - | Buy | $760.80K |
Jun 12, 2025 | WALT DAVID R | - | Buy | $224.17K |
Jun 09, 2025 | Toloue Masoud | President & CEO | Buy | $248.72K |
Jun 06, 2025 | WALT DAVID R | - | Buy | $716.58K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q4 | - | - |
2025 Q3 | 1 | - |
2025 Q2 | 6 | - |
2025 Q1 | - | - |
2024 Q4 | - | - |
QTRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools